GENERATION BIO CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 USD | -3.65% |
|
+3.57% | +75.76% |
| Apr. 12 | Transcript : Generation Bio Co. - Special Call | |
| Mar. 07 | Needham Cuts Price Target on Generation Bio to $10 From $14, Maintains Buy Rating | MT |
Presenter SpeechCameron McDonough (Executives)Good morning. Thank you for joining in the room ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet DNA (iqDNA) cargo produced by a scalable capsid-free manufacturing process that uses proprietary cell-free rapid enzymatic synthesis (RES). The Company is advancing a portfolio of programs guided by the potent and highly selective delivery of messenger ribonucleic acid (mRNA) and/or iqDNA using its ctLNP delivery system to target T cells, hematopoietic stem cells (HSCs), and hepatocytes, and intend to expand to additional tissues and cell types. Its work in T cells focuses on in vivo reprogramming of this cell type to treat cancer and autoimmune diseases.
Calendar
2024-05-01
- Q1 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
2.9
USD
Average target price
7.5
USD
Spread / Average Target
+158.62%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +75.76% | 193M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- GBIO Stock
- News Generation Bio Co.
- Transcript : Generation Bio Co. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-05-2024 09
